(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
@ $6.92
Išleistas: 14 vas. 2024 @ 21:05
Grąža: -23.07%
Ankstesnis signalas: vas. 14 - 16:30
Ankstesnis signalas:
Grąža: -1.07 %
Live Chart Being Loaded With Signals
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally...
Stats | |
---|---|
Šios dienos apimtis | 512 701 |
Vidutinė apimtis | 920 458 |
Rinkos kapitalizacija | 392.60M |
EPS | $0 ( 2024-02-27 ) |
Kita pelno data | ( $0.0400 ) 2024-05-08 |
Last Dividend | $1.600 ( 1998-01-08 ) |
Next Dividend | $0 ( N/A ) |
P/E | 7.39 |
ATR14 | $0.00300 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-26 | Datin James A | Buy | 3 217 | Common Stock |
2024-03-26 | Datin James A | Sell | 871 | Common Stock |
2024-03-01 | Mcgrath Kenneth J | Buy | 58 759 | Common Stock |
2024-03-01 | Mcgrath Kenneth J | Sell | 5 616 | Common Stock |
2024-03-01 | Anthony Michele Marie | Buy | 24 336 | Common Stock |
INSIDER POWER |
---|
67.98 |
Last 97 transactions |
Buy: 2 719 008 | Sell: 297 058 |
Tūris Koreliacija
OraSure Technologies Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
OraSure Technologies Inc Koreliacija - Valiuta/Žaliavos
OraSure Technologies Inc Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $405.47M |
Bruto pelnas: | $179.42M (44.25 %) |
EPS: | $0.730 |
FY | 2023 |
Pajamos: | $405.47M |
Bruto pelnas: | $179.42M (44.25 %) |
EPS: | $0.730 |
FY | 2022 |
Pajamos: | $387.48M |
Bruto pelnas: | $147.64M (38.10 %) |
EPS: | $-0.250 |
FY | 2021 |
Pajamos: | $233.67M |
Bruto pelnas: | $117.60M (50.33 %) |
EPS: | $-0.320 |
Financial Reports:
No articles found.
OraSure Technologies Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $1.600 | 1998-01-08 |
Last Dividend | $1.600 | 1998-01-08 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $1.600 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.32 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.02 | |
Div. Directional Score | 7.70 | -- |
Year | Amount | Yield |
---|---|---|
1998 | $1.600 | 29.80% |
1999 | $0 | 0.00% |
2000 | $0 | 0.00% |
2001 | $0 | 0.00% |
2002 | $0 | 0.00% |
2003 | $0 | 0.00% |
2004 | $0 | 0.00% |
2005 | $0 | 0.00% |
2006 | $0 | 0.00% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0 | 0.00% |
2013 | $0 | 0.00% |
2014 | $0 | 0.00% |
2015 | $0 | 0.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.132 | 1.500 | 7.35 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.111 | 1.200 | 6.30 | 7.56 | [0 - 0.3] |
returnOnEquityTTM | 0.132 | 1.500 | 9.64 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 9.77 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 8.36 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 7.35 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0280 | -1.500 | 9.53 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.575 | 2.00 | 9.47 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 1.435 | 2.00 | 9.28 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0314 | -1.500 | 9.87 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.425 | 1.000 | 6.26 | 6.26 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0901 | 1.000 | -0.198 | -0.198 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 8.57 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.840 | 0.800 | 7.73 | 6.19 | [0.5 - 2] |
Total Score | 11.37 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 7.29 | 1.000 | 9.36 | 0 | [1 - 100] |
returnOnEquityTTM | 0.132 | 2.50 | 9.77 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 1.435 | 2.00 | 9.52 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.575 | 2.00 | 9.47 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0486 | 1.500 | -3.01 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.286 | 1.000 | 5.36 | 0 | [0.1 - 0.5] |
Total Score | 4.02 |
OraSure Technologies Inc
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.